NACA4P (Gene)

Entrez:83955

Description:NACA family member 4, pseudogene

Predicted to enable unfolded protein binding activity. Predicted to be involved in protein targeting to membrane. Predicted to be part of nascent polypeptide-associated complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View NACA4P's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with NACA4P.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using NACA4P.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for NACA4P.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with NACA4P.

Results found

Linked to

	Label	Description
	GSE119978 GSE180930 cisplatin 6 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE212312 FBXW7 knockout Reh 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE212312 FBXW7 knockout Reh 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE168101 BRD4 knockout KBM-7 SLC Nucleoside Transport Proteins 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165334 dabrafenib A-375 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 paclitaxel R1192 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE212312 FBXW7 knockout Reh 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE218060 decitabine T cell 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE236502 paclitaxel 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE135514 dasatinib 2 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE212312 FBXW7 knockout Reh 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE168101 BRD4 knockout KBM-7 SLC Nucleoside Transport Proteins 1 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE165334 dabrafenib A-375 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE228106 paclitaxel R1192 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.